Learn More
Apexbio Technology LLC Cyclo(RGDyK) 250612-42-1 25mg

Supplier: Apexbio Technology LLC B601525
Cyclo RGDyK (CAS 250612-42-1) is a cyclic pentapeptide antagonist targeting integrin V 3 It is designed to competitively inhibit the interaction between integrin V 3 and ligands containing RGD motifs thereby modulating integrin-mediated cellular processes Cyclo RGDyK exerts its biological activity primarily through antagonism of V 3 integrin In preclinical experiments Cyclo RGDyK demonstrates selective inhibition of V 3 integrin with an IC50 of approximately 20 nM Based on these pharmacological properties Cyclo RGDyK holds research potential in integrin-mediated cellular process studies and tumor targeting applications
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.